Mersana Therapeutics, Inc. (MRSN)
Q2 2019 Earnings Conference Call
August 08, 2019, 08:00 ET
Company Participants
Sarah Carmody - Executive Director, Investor Relations and Corporate Communications
Anna Protopapas - President, CEO & Director
Dirk Huebner - Chief Medical Officer
Timothy Lowinger - Chief Scientific Officer
Brian DeSchuytner - SVP, Finance & Product Strategy
Conference Call Participants
Boris Peaker - Cowen and Company
John Barrett - SVB Leerink
Earl DeSouza - H.C. Wainwright & Co.
Jessica Fye - JPMorgan Chase & Co.
Presentation
Operator
Good morning, and welcome to Mersana Therapeutics Second Quarter 2019 Conference Call.